Well-differentiated hepatocellular carcinoma smaller than 15 mm in diameter totally eradicated with percutaneous ethanol injection instead of radiofrequency ablation

Hepatology International - Tập 3 - Trang 411-415 - 2009
Soo Ryang Kim1, Susumu Imoto1, Taisuke Nakajima1, Kenji Ando1, Keiji Mita1, Miyuki Taniguchi1, Noriko Sasase1, Toshiyuki Matsuoka2, Masatoshi Kudo3, Yoshitake Hayashi4
1Department of Gastroenterology, Kobe Asahi Hospital, Kobe, Japan
2Department of Radiology, Osaka City University Medical School, Osaka, Japan
3Department of Gastroenterology and Hepatology, Kinki University, School of Medicine, Osaka-Sayama, Japan
4Division of Molecular Medicine & Medical Genetics, International Center for Medical Research and Treatment (ICMRT), Kobe University Graduate School of Medicine, Kobe, Japan

Tóm tắt

We describe three cases of well-differentiated hepatocellular carcinoma (HCC) smaller than 15 mm in diameter completely eradicated with percutaneous ethanol injection (PEI) instead of using radiofrequency ablation (RFA). Ultrasound (US) examination revealed one nodule each in segment 2 (hypoechoic, near bile ducts, 10 mm), in segment 5 (hyperechoic, near the gall bladder, 15 mm), and in segment 7 (hypoechoic, near the diaphragm, 15 mm). Although imaging studies revealed isovascular (case 1) and hypervascular (cases 2 and 3) nodules, histological analysis of US-guided biopsy tissue revealed well-differentiated HCC. In consideration of the location of the nodules, PEI, instead of RFA, was administered and the nodules were rendered necrotic. Although RFA is superior to PEI in the treatment of small HCCs from the viewpoint of treatment response and long survival, PEI is strongly recommended for HCCs located near bile ducts, the gall bladder, and the diaphragm, especially when the nodules are smaller than 15 mm in diameter.

Tài liệu tham khảo

Edmondson HA, Steiner PE. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954;7:462–503 Okuda K, Peteres RL, Simson IW. Gross anatomic features of hepatocellular carcinoma from three disparate geographic areas. Proposal of new classification. Cancer 1984;54:2165–2173 Trevisani F, Caraceni P, Bernardi M, D’Intino PE, Arienti V, Amorati P, et al. Gross pathologic types of hepatocellular carcinoma in Italian patients. Relationship with demographic, environmental, and clinical factors. Cancer 1993;72:1557–1563 Okuda K. Early recognition of hepatocellular carcinoma. Hepatology 1986;6:729–738 Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999;210:655–661 Shiina S, Teratani T, Obi S, Sato S, Tateishi R, Fujishima T, et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005;129:122–130 Lin SM, Lin CJ, Lin CC, Hsu CW, Chen YC. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or = 4 cm. Gastroenterology 2004;127:1714–1723 Cho YK, Kim JK, Kim MY, Rhim H, Han JK. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapy. Hepatology 2009;49:453–459 Kasugai H, Osaki Y, Oka H, Kudo M, Seki T, Osaka Liver Cancer Study Group. Severe complications of radiofrequency ablation therapy for hepatocellular carcinoma: an analysis of 3891 ablations in 2614 patients. Oncology 2007;72:S72–S75 Takeuchi H, Arata T, Takehara K, Shigeyasu K, Kanazawa T, Murata H, et al. A patient who developed diaphragmatic hernia one year after percutaneous radiofrequency ablation for hepatocellular carcinoma. Kanzo 2007;48:458–462 Tomonaga C, Kawano A, Taguchi Y, Matsunaga T, Maruyama T, Toyoshima S, et al. Two cases of diaphragmatic hernia following percutaneous radiofrequency ablation of hepatocellular carcinoma. Kanzo 2007;48:529–537 Kanai T, Hirohashi S, Upton MP, Noguchi M, Kishi K, Makuuchi M, et al. Pathology of small hepatocellular carcinoma. A proposal for a new gross classification. Cancer 1987;60:810–819 Nakashima O, Sugihara S, Kage M, Kojiro M. Pathomorphologic characteristics of small hepatocellular carcinoma: a special reference to small hepatocellular carcinoma with indistinct margins. Hepatology 1995;22:101–105 Kojiro M, Nakashima O. Histopathologic evaluation of hepatocellular carcinoma with special reference to small early stage tumors. Semin Liver Dis 1999;19:287–296 Kondo Y, Niwa Y, Akikusa B, Takazawa H, Okabayashi A. A histopathologic study of early hepatocellular carcinoma. Cancer 1983;52:687–692 Nakashima T, Kojiro M. Hepatocellular Carcinoma: An Atlas of its Pathology. Tokyo: Springer-Verlag; 1987 Vilana R, Bruix J, Bru C, Ayuso C, Sole M, Rodes J. Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology 1992;16:353–357 Kojiro M. The evolution of pathologic features of hepatocellular carcinoma. In Tabor E, editor. Viruses and Liver Cancer. Amsterdam: Elsevier; 2002. 113–122 Kojiro M. Pathology of Hepatocellular Carcinoma. Oxford: Blackwell; 2006. 39–49 Taniguchi M, Kim SR, Imoto S, Ikawa H, Ando K, Mita K, et al. Long-term outcome of percutaneous ethanol injection therapy for minimum-sized hepatocellular carcinoma. World J Gastroenterol 2008;14:1997–2002